Lv5
1230 积分 2024-08-13 加入
Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod
14小时前
待确认
Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis
16小时前
已完结
Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer
7天前
已完结
Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients
7天前
已完结
FAPα-TARGETED IMMUNOTHERAPY WITH SIBROTUZUMAB AND HIGH AFFINITY FC-RECEPTOR EXPRESSING NK92 CELLS: A PROMISING APPROACH TO REVERSE FIBROSIS
7天前
已完结
Functionally distinct fibroblast subsets in RA
9天前
已完结
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms
9天前
已完结
[2024 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis]
9天前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
29天前
已完结
Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
1个月前
已完结
皖公网安备34019202002308
